Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
The evidence base is preclinical for IGF-1 LR3 specifically, with adjacent human data from native rhIGF-1 (mecasermin/Increlex)
British Journal of Pharmacology , 163 (7), 13441364
Syn-Ake works by blocking the nicotinic acetylcholine receptor providing a complementary and synergistic mechanism to SNAP-8's SNARE complex inhibition
Muscular endurance for higher repetition work improves as cellular energy production optimizes
Other methods, like intravenous injection, can be difficult and costly
If particles remain after 5 minutes of gentle swirling, the peptide may be degraded
US$ 22.07
US$ 20.14
US$ 20.62
US$ 20.00
US$ 24.29
US$ 27.60
US$ 29.35
